New York, May 27, 2026, 10:01 (EDT)
- AMASS Brands finished its latest session at $6.62, up $3.04. The stock moved between $3.65 and $15.05 earlier in the day.
- Good Twin is now the leading U.S. organic non-alcoholic wine by dollar share, the company said, pointing to Nielsen data.
- Streeterville Capital bought $6.99 million in Series C convertible preferred stock, according to a new SEC filing.
Shares of AMASS Brands Inc. surged at the open on Nasdaq Wednesday, with the stock swinging again in its first week since listing. The drinks company pointed to rising sales at its Good Twin wine line and said it secured new convertible funding.
AMSS was last at $6.62, jumping $3.04 from its last close. Around 13.6 million shares changed hands. The stock swung from a high of $15.05 to a low of $3.65, a big range for a new micro-cap listing.
AMASS is still feeling out its price in the market after listing its common stock on Nasdaq on May 20. The company used a direct listing, which put existing shares on the market but didn’t include a sale of new common stock.
AMASS said Wednesday its Good Twin brand is now the top organic non-alcoholic wine by dollar share in the U.S., based on Nielsen retail sales for the four weeks ending April 18. The ranking measures share by sales value, not volume.
Good Twin grabbed 35.43% of the dollar share in the organic non-alcoholic wine segment and picked up 12.93 share points from last year, according to AMASS. The company reported 122.2% year-over-year dollar sales growth and a 115.0% jump in volume. The total organic non-alcoholic wine category grew 41.1% in the period, AMASS said.
Good Twin is still in the “early stages” of its U.S. rollout, but CEO Mark Thomas Lynn said the brand’s “continued momentum” suggests AMASS can scale brands that match new consumer trends. “We remain in the early stages of Good Twin’s national expansion opportunity,” Lynn said. GlobeNewswire
Shares gained after a new SEC filing showed AMASS finished a second closing in its securities deal with Streeterville Capital. AMASS sold 7,000 Series C convertible preferred shares for $6.99 million in total. The preferred shares can be converted into common under the agreement.
Those terms are a double-edged sword. According to the filing, conversions have a 9.99% beneficial-ownership limit and a Nasdaq exchange cap, which put a ceiling on how much common stock can be issued at once. Still, the structure can raise dilution questions for current holders.
AMASS is pushing to establish itself as a multi-brand beverage platform, featuring non-alcoholic options, functional drinks and what it calls “alcohol 2.0”—its label for newer alcohol types and premium formats. The lineup includes Good Twin Non-Alcoholic Wine and Summer Water Rosé. At its listing, the company said it had booked over $80 million in total revenue and sold more than 5.7 million bottles since launch. Securities and Exchange Commission
The beverage sector traded higher, but AMASS outpaced the bigger names. Shares of Constellation Brands were up around 2.1%. Boston Beer picked up 3.5%. Celsius Holdings was ahead 6.4% early, market data showed.
There’s still plenty of risk. AMASS’s May 4 registration statement showed 2025 net revenue of $17.8 million, with a $17.2 million net loss. The company also warned about possible stock dilution and price pressure from the Streeterville preferred financing.
Investors are moving in and out of a small, newly listed beverage stock on some new branding numbers and a financing update. The stock’s early days have been volatile. Moves could easily swing back, given the short trading history.
